Pharmadrug (TSE:PHRX) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PharmaDrug Inc. has successfully issued over $412,000 in debentures to replace its outstanding secured convertible debentures, along with over 8 million common share purchase warrants. These debentures, convertible into common shares at $0.05 each, are secured by a general security agreement and carry no interest unless unpaid at maturity, marking a strategic financial move for the company.
For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.